Position in TRLV
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$1,150,807
New position
Shares Held
117,071
first reported quarter
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $93,224,797 across 28 Drug Manufacturers - Specialty & Generic names. TRLV ranks #16 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
487,990 | $35,066,961 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
54,680 | $9,215,766 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
342,271 | $8,423,288 | |
| 4 | VTRS |
Viatris Inc
|
471,938 | $7,494,374 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
13,429 | $7,276,234 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
209,792 | $3,039,885 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
150,698 | $2,608,582 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
71,870 | $2,601,694 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,150,807 | 117,071 | Shares | Sole | 2026-08-27 | |
| No filing history on record for this holder in this stock. | ||||||